Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats

被引:125
作者
Bosquillon, C [1 ]
Prat, W [1 ]
Vanbever, R [1 ]
机构
[1] Catholic Univ Louvain, Sch Pharm, Dept Pharmaceut Technol, B-1200 Brussels, Belgium
关键词
inhalation dry powders; human growth hormone; pulmonary absorption; dipalmitoylphosphatidylcholine; alveolar macrophages;
D O I
10.1016/j.jconrel.2004.01.027
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A dry powder aerosol formed of human growth hormone (hGH), lactose and dipalmitoylphosphatidylcholine was assessed for systemic delivery of the hormone in rats. The fate of the protein locally in the deep lung was examined post-delivery. The powder was prepared by spray-drying and presented a primary particle diameter of 4.4 mum and a tap density of 0.069 g/cm(3). The mass median aerodynamic diameter was 4.4 pm in the multi-stage liquid impinger at 60 1/min using a Spinhaler(TM) device. The emitted dose and fine particle fraction were 89% and 58%, respectively. Varying the airflow rate from 30 to 90 1/min had limited impact on aerosolization properties in vitro. No hGH dimers or glycation adducts were produced during formulation of the powder. hGH absorbed into the bloodstream with a time to peak of 23 and 52 min and with an absolute bioavailability of 23% and 8% following intratracheal insufflation of the dry powder and intratracheal spray-instillation of a solution of the hormone, respectively. Confocal imaging of rat lung revealed an intense uptake of fluorescein isothiocyanate (FITC)-hGH by alveolar macrophages as early as 1 h post-delivery. A dry powder aerosol made of selected GRAS excipients improved absorption of hGH from the lung over a simple solution. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:233 / 244
页数:12
相关论文
共 31 条
[1]  
Adjei A.L, 1997, INHALATION DELIVERY, pxiii
[2]   The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody [J].
Andya, JD ;
Maa, YF ;
Costantino, HR ;
Nguyen, PA ;
Dasovich, N ;
Sweeney, TD ;
Hsu, CC ;
Shire, SJ .
PHARMACEUTICAL RESEARCH, 1999, 16 (03) :350-358
[3]   CHEMICAL, PHYSICAL, AND BIOLOGICAL CHARACTERIZATION OF A DIMERIC FORM OF BIOSYNTHETIC HUMAN GROWTH-HORMONE [J].
BECKER, GW ;
BOWSHER, RR ;
MACKELLAR, WC ;
POOR, ML ;
TACKITT, PM ;
RIGGIN, RM .
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 1987, 9 (06) :478-487
[4]   Comparison of particle sizing techniques in the case of inhalation dry powders [J].
Bosquillon, C ;
Lombry, C ;
Preat, V ;
Vanbever, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (12) :2032-2041
[5]   Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance [J].
Bosquillon, C ;
Lombry, C ;
Préat, V ;
Vanbever, R .
JOURNAL OF CONTROLLED RELEASE, 2001, 70 (03) :329-339
[6]  
Cholewinski M, 1996, Pharm Acta Helv, V71, P405, DOI 10.1016/S0031-6865(96)00049-0
[7]   Impact of formulation and methods of pulmonary delivery on absorption of parathyroid hormone (1-34) from rat lungs [J].
Codrons, V ;
Vanderbist, F ;
Ucakar, B ;
Préat, V ;
Vanbever, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (05) :1241-1252
[8]   Systemic delivery of parathyroid hormone (1-34) using inhalation dry powders in rats [J].
Codrons, V ;
Vanderbist, F ;
Verbeeck, RK ;
Arras, M ;
Lison, D ;
Préat, V ;
Vanbever, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (05) :938-950
[9]   THE INFLUENCE OF REGIONAL DEPOSITION ON THE PHARMACOKINETICS OF PULMONARY-DELIVERED HUMAN GROWTH-HORMONE IN RABBITS [J].
COLTHORPE, P ;
FARR, SJ ;
SMITH, IJ ;
WYATT, D ;
TAYLOR, G .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :356-359
[10]  
DALBOGE H, 1988, DAN MED BULL, V35, P84